- Tap to contact1Poster
Integrative Functional and Molecular Profiling for Precision Therapy in Soft Tissue Sarcomas (NEWDEAL project)
Alessandro De Vita
- Tap to contact2Poster
Molecular profiling of undifferentiated soft tissue sarcoma
Néis Lartigue
- Tap to contact3Poster
N-acetyl-L-cysteine impairs MNNG/HOS osteosarcoma cells aggressiveness
Argia Ucci
- Tap to contact4Poster
Development and Characterization of 3D Osteosarcoma Models Recapitulating Tumor Heterogeneity and the Bone Microenvironment
Margaux Chantoiseau
- Tap to contact5Poster
Spatial and Single-Cell Proteomics of Relapsed Osteosarcoma Reveals a Targetable Landscape
Ashok Kumar Jayavelu
- Tap to contact6Poster
Targeting Chemoresistance in Sarcomas through drug combinations
Ana S. Indurain
- Tap to contact7Poster
Genome-wide CRISPR screening identifies synthetic lethalities interactions to enhance mithramycin efficacy in osteosarcoma
Carmen Huergo
- Tap to contact8Poster
Targeting cisplatin-resistant osteosarcoma using liposomal nanoencapsulation of a ruthenium-based metallodrug
Enol Álvarez-González
- Tap to contact9Poster
Engineering 3D osteosarcoma coculture models for improved in vitro drug response evaluation
Andrea Ferreras
- Tap to contact10Poster
Targeting the soft tissue sarcoma microenvironment with LOX-directed epirubicin liposomes: preclinical evidence from the PEGASO project
Silvia Vanni
- Tap to contact11Poster
RERE and the Mediator complex mediate EWSR1::FLI1-induced Alternative Splicing, a therapeutically targetable vulnerability in Ewing sarcoma
Irene Cuervas
- Tap to contact12Poster
Activation of Innate Immune Signalling pathways in Osteosarcoma
Mingyue Gao
- Tap to contact13Poster
ERK5 PROTAC Therapy Rewires the Osteosarcoma Immune Microenvironment
Charlotte Frampton
- Tap to contact14Poster
From the Tumour Microenvironment to Next-Generation CAR T Cells in Osteosarcoma
Carmen Rodríguez
- Tap to contact15Poster
Multiomic profiling of human and canine soft-tissue sarcomas reveals extensive molecular homology across species and identifies clinically relevant subgroups
Daniel Fuchs
- Tap to contact16Poster
Investigating RNA structure dysregulation in Fusion-positive Rhabdomyosarcoma
Kirsty Soanes
- Tap to contact17Poster
Identification of tumor-secreted factors in the formation of a premetastatic niche in rhabdomyosarcoma
Beate Furevik
- Tap to contact18Poster
Understanding the oncogenic mechanisms of sarcomas with BCOR rearrangements
Audrey Mansilha
- Tap to contact19Poster
Development of osteosarcomas by Opg -/- mice: implications of oncogenic fusion proteins secondary to tetraploidy-induced genomic instability
Aline Lessa
- Tap to contact20Poster
Functional drug screening reveals vulnerabilities in clear cell sarcoma
Djenana Vejzovic
- Tap to contact21Poster
Localized inducible delivery of IL-12 via AAV-scIL-12 demonstrates efficacy and safety in murine osteosarcoma models
M. C. Ochoa
- Tap to contact22Poster
A Functional Screening Platform to Test Therapy Response in Sarcoma Patient-Derived Models
Alexander Carneiro-Figueira / Mayan
- Tap to contact23Poster
Investigating the causes and consequences of RNA structure dysregulation in Ewing sarcoma
Amy M. Harden
- Tap to contact24Poster
Oncolytic virus–monoclonal antibody combination therapies to overcome immunosuppressive effects of the osteosarcoma tumour microenvironment
Tyler Barr
- Tap to contact25Poster
Spatial transcriptomics analysis reveals tumor cell plasticity and diverse tumor microenvironments in Ewing sarcoma
Heng Luo
- Tap to contact26Poster
Osteosarcoma-educated osteoclasts possess an immune-related signature
Daria Klusa
- Tap to contact27Poster
Remodeling cellular communications promotes osteosarcoma recurrence
Polina Perepelkina
- Tap to contact28Poster
Profiling of B-cell Dynamics Identifies Prognostic Immune Niches in Undifferentiated Pleomorphic Sarcoma
Monika Ehnman
- Tap to contact29Poster
Osteosarcoma cells undergo transient cell cycle arrest and transcriptional rewiring enabling survival after MAP chemotherapy in vitro
Justas Stanislovas
- Tap to contact30Poster
Pre-clinical validation of OSCAR-3 mRNA-based CAR T cells for targeting osteosarcomas
Nadia Mensali
- Tap to contact31Poster
Magnetite-based nanoparticles as a platform for hyperthermia and drug delivery in osteosarcoma
Joshua Mountford
- Tap to contact32Poster
Collagen-targeting IL-12 combined with doxorubicin enhances anti-tumour effects against osteosarcoma
Jun Ishihara
- Tap to contact33Poster
Unravelling the epigenetic mechanisms of Aurora Kinase B inhibition in Ewing sarcoma
María Sánchez-Jiménez
- Tap to contact34Poster
The role of ACF1 in DNA replication stress imposed by EWSR1::FLI1 in Ewing sarcoma
Carla Rios-Astorch
- Tap to contact35Poster
Identification of novel drugs for osteosarcoma treatment
Md Mahamudul Alam
- Tap to contact36Poster
MicroRNA Profiling in Chondrosarcoma
Mritunjoy Dey
- Tap to contact37Poster
Marine-derived hydrogels for 3D sarcoma cell culture and cancer drug screening
Maria Ester Salvucci
- Tap to contact38Poster
MicroRNA-based tissue identity distinguishes sarcoma from other cancer lineages and identifies prognostically relevant biomarkers
Mritunjoy Dey
- Tap to contact39Poster
User participation in paediatric cancer research — perspectives from Norway and the Children's Cancer Society Norway
Bitte Stenvik
- Tap to contact40Poster
Optimization of protocol for sorting circulating tumor cells in patients with sarcoma
Quentin Vallée
- Tap to contact41Poster
Radiotherapy-driven tumour microenvironment remodelling enhances CAR-T cell therapy in rhabdomyosarcoma
Virginia Laspidea
- Tap to contact42Poster
The role of metabolic adaptation in osteosarcoma metastasis
Elisabeth Weigert
- Tap to contact43Poster
Osteosarcoma plasma-derived extracellular vesicles display distinct cytokine signatures
Snehadri Sinha
- Tap to contact44Poster
Epigenetic regulation of liposarcoma giant rod chromosomes
Ragnhild Eskeland
- Tap to contact45Poster
CRISPR/Cas9-mediated identification of genes that modulate drug efficiency in osteosarcoma
Patricia Testori
- Tap to contact46Poster
Transcription Factor driven Enhancer reprogramming in Osteosarcoma
Ragnhild Eskeland
- Tap to contact47Poster
DogBiTE: A novel Bispecific T Cell Engager Platform to Enhance Translational Predictability in Immuno-Oncology
Pascal Gelebart
- Tap to contact48Poster
A chimeric CSPG4-targeted DNA vaccine to overcome chemoresistance and rewire osteosarcoma treatment
Lidia Tarone
- Tap to contact49Poster
The novel endogenous lncRNA MERT1 potentiates metastasis in paediatric sarcomas but is amenable to Omomyc
Emma Bull
- Tap to contact50Poster
A RUNX2-AL096865.1 regulatory module links chromatin accessibility and osteogenic transcriptional state in osteosarcoma
Yevheniia Kovalova
- Tap to contact51Poster
Acidic tumor microenvironment promotes S1P-mediated histone acetylation to increase osteosarcoma aggressiveness
Margherita Cortini

